‘One Health’ Approach Is Necessary to Address Rising Environmental Causes of Childhood Cancers
A multi-disciplinary, “One Health” approach to cancer research is necessary to guide society in reduction of toxic substances, as well as regulation of chemical impacts on the environment and public health, according to an editorial published...
6-Jul-2022 5:05 PM EDT
Add to Favorites
VR-Integrated Rehab for Cancer Patients Shows Potential in Research Review
Oncology researchers using Virtual Reality (VR) in the treatment of cancer patients have published a review of the existing literature regarding the application of this technology for the rehabilitation of cancer survivors.
6-Jul-2022 3:45 PM EDT
Add to Favorites
Drug Repurposing Identifies New Candidates to Treat Mesothelioma
A group of researchers have identified potential novel drug candidates for the treatment of Malignant Pleural Mesothelioma (MPM).
28-Jun-2022 9:00 AM EDT
Add to Favorites
Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology
There is a growing awareness that the design of clinical trials can be misleading and provide evidence that does not end up actually benefiting patients in the clinical setting.
27-Jun-2022 3:00 PM EDT
Add to Favorites
Public Health Conference: 2022 Theme: Response to COVID-19 and Impact of the Pandemic
Public Health conference hosted by Temple University Rome and Temple College of Public Health.
9-May-2022 1:30 PM EDT
Add to Favorites
Targeting Cervical Cancer Stem Cells to Improve Outcomes
The presence of Cervical Cancer Stem Cells (CCSCs) in cases of Cervical Cancer (CC) represent a small subpopulation of tumor cells with a high potential for resistance to conventional treatments.
6-May-2022 10:35 AM EDT
Add to Favorites
New Mesothelioma Drugs, Once Hailed as Gamechangers, Don’t Live Up to the Hype
Malignant Pleural Mesothelioma (MPM) is an aggressive cancer mostly related to asbestos exposure whose incidence is constantly rising, especially in low-income countries.
10-Mar-2022 6:05 AM EST
Add to Favorites
Cancer Immunotherapy Is Not the Holy Grail: A New Study Casts a Shadow
Recently approved drugs to boost the immune response against cancer represents a novelty that should not be over-hyped, researchers say
27-Dec-2021 5:05 PM EST
Add to Favorites
See All News
Precision Medicine and the Anti-Cancer Properties of Foods like Green Tea, SHRO Founder Comments
2-Mar-2021 8:15 AM EST
"We've got to get our act together" on public health measures to combat COVID, says Fauci
3-Nov-2020 2:35 PM EST
‘Genetic Shield’ May Explain Lower COVID Mortality in Southern Italy Compared to North
4-Jun-2020 9:55 AM EDT
Coronavirus: concern and precaution ok, but panic and hysteria unjustified, says expert
COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly
6-Mar-2020 8:20 AM EST
Cancer DNA Sequencing Has Potential, but Not a Magic Bullet, Says Expert
16-Jan-2018 11:05 AM EST
Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert
Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT
Every Diagnosis of Cancer Should Come with One of These, Says Cancer Expert
“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST